Miss Marijuana

JANUARY 30, 2025

Clinical trials have been looking into both THC and CBD and their individual roles in treating anxiety. Some research suggests that cannabis could be an effective option for managing anxiety, especially in lower doses. But high doses? Well, they can sometimes have the opposite effect. The takeaway?

Treatment 52

Treatment Microdosing Indica Terpenes 52

Veriheal

JUNE 12, 2025

A four-week clinical trial found that Spravato, when combined with an oral antidepressant, led to greater reductions in depression symptoms compared to a placebo with an oral antidepressant. Clinical trials show that patients begin experiencing significant shifts in their depression symptoms after four weeks of treatment.

Therapy 69

Therapy Treatment Clinical Trials Blood Pressure 69

NORML

OCTOBER 30, 2020

The post Clinical Trial: Plant-Derived Cannabis Oil Effective for Patients with Fibromyalgia appeared first on NORML. "We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients.".

Clinical Trials 247

Clinical Trials Oil Patients Therapy 247

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 271

Clinical Trials Chronic Pain Cannabinoids Patients 271

NORML

FEBRUARY 16, 2021

“This study demonstrates that treatment with THC-rich cannabis in patients with mild to moderate UC is associated with clinical improvement.". The post Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis appeared first on NORML.

Clinical Trials 246

Clinical Trials Patients Treatment THC 246

NORML

FEBRUARY 25, 2020

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care.

Clinical Trials 255

Clinical Trials THC Consumption Therapy 255

NORML

FEBRUARY 4, 2021

“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".

Clinical Trials 247

Clinical Trials Extraction Patients Treatment 247

Veriheal

JUNE 26, 2025

Since its formation, MAPS has led campaigns and research projects to advance medical research on psychedelic substances, conducted clinical trials on MDMA-assisted therapy, and raised over $140 million in donations for education and research.

Clinical Trials 52

Clinical Trials Therapy Research and Development Treatment 52

Project CBD

JANUARY 1, 2022

New studies highlight therapeutic potential of cannabinoids for cancer, but clinical trials are lacking.

Clinical Trials 359

Clinical Trials Cannabinoids 359

NORML

MAY 21, 2019

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry.

Clinical Trials 197

Clinical Trials CBD History Data 197

Cannabis Life Network

OCTOBER 14, 2021

Even as a common name, CBG had yet to undergo the same tests and clinical trials as CBD to ensure high doses are safe. The post CBG is safe, gets green light for clinical trials and therapy appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks.

Clinical Trials 122

Clinical Trials Therapy Cannabinoids CBD 122

Veriheal

JUNE 17, 2021

However, there has not been a clinical trial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinical trial for cannabis as a migraine treatment is underway. The First Clinical Trial for Migraines and Cannabis.

Clinical Trials 98

Clinical Trials Treatment Patients Cannabis 98

Cannabis Life Network

NOVEMBER 18, 2020

announced early this morning that it will undertake a clinical trial of psilocybin-assisted psychotherapy. The compassionate access clinical trial will enable the company to refine optimal protocols for the use of psilocybin-assisted psychotherapy for participants with a range of substance use disorders.

Clinical Trials 98

Clinical Trials Access Therapy Events 98

Cannabis Life Network

JULY 5, 2022

Clinical evidence, however, has yet prove that cannabinoids, terpenes, or cannabis treat cancer. With or without clinical trials, though, cancer patients who medicate with cannabis remain optimistic in Canada and The Netherlands. (1, 1, 2) Before legalization in […].

Clinical Trials 105

Clinical Trials Patients Terpenes Treatment 105

Cannabis Law Report

MAY 26, 2021

MindMed (Nasdaq: MNMD) announced today that its clinical trial plans to evaluate the acute effects of serotonergic hallucinogen mescaline have… Read More.

Clinical Trials 98

Clinical Trials 98

Project CBD

JUNE 19, 2019

The launch of a clinical trial examining the use of CBD in newborns suffering from hypoxic ischemic encephalopathy (brain damage caused by lack of oxygen) means new hope for the million plus babies born each year with this condition. Giving medical cannabis to infants is a difficult taboo to shift, but new research is paving the way.

Clinical Trials 274

Clinical Trials CBD Conditions Cannabis 274

Project CBD

MARCH 2, 2020

Recently NIDA supported a clinical trial which used nicotine as a therapy for relatively mild cannabis withdrawal symptoms.

Clinical Trials 269

Clinical Trials Therapy Recreational Cannabis 269

Cannabis Law Report

JULY 21, 2021

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. . This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. SOURCE Wake Network, Inc.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

NORML

DECEMBER 18, 2020

This study’s primary outcome supports the theory that cannabis should be [tested in clinical trials] as a potential therapeutic for PTSD.". “This study provides evidence that the types of cannabis available in recreational and medical cannabis dispensaries might hold promise as an alternative treatment for PTSD.

Clinical Trials 247

Clinical Trials Patients Treatment Dispensary 247

NORML

JULY 25, 2022

The Act provides the office of the US Attorney General with a 60-day timeline to either approve or deny the applications from scientists wishing to engage in clinical trials involving the use of cannabis by human subjects.

Legislation 237

Legislation Clinical Trials Cannabis 237

Cannabis Law Report

JANUARY 17, 2021

The post NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials first appeared on Cannabis Law Report. We hope he does a better job than some of the playlists we’ve seen recently ! NeonMind Biosciences Inc. … Read More.

Clinical Trials 97

Clinical Trials Programs Law Cannabis 97

NORML

APRIL 30, 2020

” This finding is hardly a surprise, as cannabis is well-established to mitigate pain in clinical models, particularly in patients with neuropathy. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5 percent in 2016).”

Chronic Pain 343

Chronic Pain Clinical Trials Data Patients 343

Project CBD

OCTOBER 10, 2019

Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2.

Cannabinoids 229

Cannabinoids Clinical Trials Research and Development Pharmaceutical 229

Americans for Safe Access

JUNE 2, 2020

This new agency, the Office of Medical Cannabis Control (OMCC), would be tasked with overseeing not only the requirements of the research program, but would also enable cultivators that are already licensed in medical cannabis states to provide high quality medical cannabis to researchers, thereby increasing the diversity of products that can be used (..)

Clinical Trials 264

Clinical Trials DEA History Cultivation 264

Cannabis Law Report

MAY 11, 2021

Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial. VANCOUVER, BC, May 11, 2021 /CNW/… Read More.

Clinical Trials 93

Clinical Trials Extraction Cannabis 93

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

Cannabis Law Report

JUNE 29, 2021

We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board. Research in the area of mental health has been Dr. Nitin Desai’s passion. ” About Ehave, Inc.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

NORML

JANUARY 17, 2019

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. .

Clinical Trials 231

Clinical Trials Legislation DEA Patients 231

NORML

JULY 26, 2019

Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research. Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality.

Clinical Trials 196

Clinical Trials Marijuana Strains THC 196

NORML

MARCH 30, 2020

By contrast, they reported that there exists “no evidence from properly designed clinical trials to support the use of CBD for the treatment” of these or other conditions, such as the flu, West Nile virus, Ebola, or common cold viruses. However, this data was based solely on preclinical findings.

CBD 299

CBD Clinical Trials Data Treatment 299

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Los Angeles, California. www.InvestorBrandNetwork.com. 310.299.1717 Office.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

AUGUST 24, 2021

Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. TORONTO–(BUSINESS WIRE)–FSD Pharma Inc.

Clinical Trials 81

Clinical Trials Treatment Pharmaceutical Concentrates 81

NORML

DECEMBER 6, 2019

The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine.

Clinical Trials 109

Clinical Trials Patients CBD Therapy 109

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 353

Cultivation DEA Clinical Trials Marijuana 353

Cannabis Law Report

JULY 19, 2021

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.

Clinical Trials 76

Clinical Trials Research and Development Hybrid Medicine 76

NORML

JANUARY 31, 2019

Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Twenty percent of those surveyed acknowledged having previously used cannabis for medical purposes.

Clinical Trials 208

Clinical Trials Chronic Pain Data Treatment 208